Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
Quant Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesAster DM Healthcare Limited8.020770516435.2547
Domestic EquitiesRPG Life Sciences Limited7.722015306733.9418
Domestic EquitiesHFCL Limited7.0192239000030.8525
Domestic EquitiesPfizer Ltd6.93205734630.4694
Domestic EquitiesReliance Industries Limited6.914523520030.3925
Domestic EquitiesAurobindo Pharma Limited6.241921730027.4363
Domestic EquitiesSequent Scientific Limited6.2276134632027.3734
Domestic EquitiesZydus Lifesciences Limited6.192328177727.2182
Domestic EquitiesGlenmark Life Sciences Limited6.074724629826.7012
Domestic EquitiesIPCA Laboratories Ltd6.001117100026.3776
Domestic EquitiesZydus Wellness Ltd5.912812834625.9894
Domestic EquitiesGlaxosmithkline Pharmaceuticals Ltd5.616810100024.6884
Domestic EquitiesAarti Pharmalabs Limited4.050428085217.8032
Domestic EquitiesSMS Pharmaceuticals Limited3.929566188617.2719
Domestic EquitiesSuraksha Diagnostic Limited3.412634013615.0000
Domestic EquitiesTorrent Pharmaceuticals Ltd2.59403430011.4020
Domestic EquitiesSuven Life Sciences Ltd.2.450583000010.7709
Domestic EquitiesAlembic Pharmaceuticals Limited1.0034403804.4103
Domestic EquitiesThyrocare Technologies Limited0.9284407944.0808
Domestic EquitiesSanofi Consumer Healthcare India Limited0.867379003.8121
Domestic EquitiesAmi Organics Limited0.8564175663.7643
Total 98.9680 435.0109
Cash & Cash Equivalents and Net AssetsTREPS 02-Dec-2024 DEPO 100.321014121.4110
Cash & Cash Equivalents and Net AssetsNCA-NET CURRENT ASSETS-0.4101 -1.8025
Total -0.0891 -0.3915
Treasury Bills91 Days Treasury Bill 21-Feb-20251.12115000004.9277
Total 1.1211 4.9277
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.